Brincidofovir
Back to searchMolecule Structure
Scientific Name
Brincidofovir
Description of the Drug
Brincidofovir is an oral lipid prodrug of cidofovir used in the treatment of human smallpox disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12151
http://www.drugbank.ca/drugs/DB12151
Brand Name(s)
Tembexa
Company Owner(s)
Chimerix Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA polymerase | SINGLE PROTEIN | INHIBITOR | CHEMBL3988586 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL139922 |
| DrugBank | DB12151 |
| PubChem: Thomson Pharma | 14764062 |
| PubChem | 483477 |
| Nikkaji | J2.075.976C |
| EPA CompTox Dashboard | DTXSID60196190 |
| ChemicalBook | CB02627690 |
| PubChem: Drugs of the Future | 57304396 |
| ZINC | ZINC000014141521 |
